Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

<ul class="summary-list"><li>Melissa Ramirez's son Jax has <keyword id="13451449" type="UNKNOWN" weightage="60" keywordseo="ipex-syndrome" source="Orion">IPEX syndrome</keyword>.</li><li>This syndrome can be cured only with a bone-marrow transplant.</li></ul>Melissa Ramirez says her 7-year-old son, Jax, is happy all the time."He's a natural storyteller," she told Insider. When he was 3, she once found a ring of people standing spellbound as he told a tale. "I feel like he could run for the United Nations," a neighbor said. When Jax was 2, they found out he had <a href="https://www.insider.com/what-causes-type-1-diabetes">type 1 diabetes</a>. It was only the beginning of his complicated medical journey. Every cold sent Jax to the emergency room or the pediatric intensive-care unit. But Ramirez said doctors brushed off her demands for more answers, saying Jax was just unlucky. After they had a genetic panel done in fall 2021, they discovered Jax had immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome, or <a href="https://www.stanfordchildrens.org/en/service/stem-cell-transplantation/conditions/ipex-syndrome">IPEX</a>. Jax's body has an autoimmune response to attack every organ and healthy tissue in his body. Ramirez said medical personnel cried over the phone when they told her Jax's diagnosis and warned, "Don't Google." IPEX can be cured only with <a href="https://www.insider.com/bone-marrow-transpant-donor-meeting-2016-1">human stem-cell transplants</a> via <a href="https://www.insider.com/mom-registers-black-bone-marrow-donors-to-save-her-son-2021-3">bone-marrow</a> donation. But Jax, who is mixed-race, has no match. His mother is white of Slovak, German, and Irish descent. His father, from Mexico, is Latino.The mother of a white daughter with IPEX told Ramirez, "I think your experience is going to be a little different from ours." Her white child had 10 pages of matched donors, while Jax had none. <h2>The bone-marrow donor pool lacks diversity</h2><a href="https://www.dkms.org/get-involved/stories/why-diversity-is-essential">DKMS</a>, called "Deutsche Knochenmarkspenderdatei," or the German Bone Marrow Donor Center, which works with patients worldwide, said only 30% of patients who need human stem-cell transplants would find that match within their families. Other patients are matched through databases that compare "10 specific human leukocyte antigens," or HLAs, which play a role in the body's immune response to foreign substances. Nine out of 10 of those must match, and 10 out of 10 is best. DKMS said, "A person's ethnic background is important in predicting the likelihood of finding a match."And nonwhite people are underrepresented in the donor pool. The bone-marrow registry <a href="https://bethematch.org/transplant-basics/matching-patients-with-donors/how-does-a-patients-ethnic-background-affect-matching/">Be the Match</a> said white people had a 79% chance of finding a matching donor. That dropped to 60% for Native Americans and 48% for Latinos. For Black people, the chance of finding a match was 29%. Only 4% of donors registered with <a href="https://www.cancer.net/blog/2021-03/why-bone-marrow-registry-needs-more-diverse-donors-and-how-sign">Be the Match</a> were Black. In many cases, people unable to find a match died. <h2>Jax's mom is fighting to find him a donor</h2>People of mixed-race backgrounds are at an even greater disadvantage. Their HLA markers tend to be "relatively unique and therefore more difficult to match," according to Be the Match.Be the Match calls Jax, with his mixed-race ancestry, "one in a million.""I've never won the lottery, not so much as a scratch-off card," said Ramirez, his mother. "But this is one lottery I'm going to win."So she's fighting hard. As of the end of March, Ramirez will have overseen 70 live swabbing events to register bone-marrow donors since November. These have included drives in Texas and Mexico. She's registered 2,900 people because of Jax. "Every time, I raise my goal by 500 people," she said. She's also enlisted the second lady of Pennsylvania, <a href="https://johnfetterman.com/meet/giseles-story/">Gisele Fetterman</a>, in her fight to spread the word about Jax's condition and help raise awareness about the need for a more diverse donor pool, both in their home state and beyond. Fetterman is also the mom of multiracial children. Jax needs a transplant desperately, and Fetterman believes there's hope. "This is something we have the power to change," she said.

A 7-year-old boy needs a bone-marrow transplant. Being mixed-race makes it almost impossible to find one.

<ul class="summary-list"><li>GOP Reps. Greene and Boebert voted against a bill that would renew the National Marrow <keyword id="6398461" type="UNKNOWN" weightage="60" keywordseo="donor">Donor</keyword> Program.</li><li>The program helps match <keyword id="6631668" type="UNKNOWN" weightage="60" keywordseo="bone-marrow">bone marrow</keyword> donors with leukemia patients.</li><li>"Nothing in this bill prevents the funding of aborted fetal tissue," a spokesman for Greene said.</li></ul>GOP Reps. <keyword id="9740457" type="UNKNOWN" weightage="60" keywordseo="marjorie-taylor-greene">Marjorie Taylor Greene</keyword> of Georgia and <keyword id="10543170" type="UNKNOWN" weightage="60" keywordseo="lauren-boebert">Lauren Boebert</keyword> of Colorado were the only members of <keyword id="1575" type="ORGANIZATION" weightage="60" keywordseo="Congress">Congress</keyword> to vote against a bill that would provide patients who suffer from leukemia or other blood diseases access to potentially life-saving bone marrow transplants.The legislation, called the TRANSPLANT Act, would reauthorize the National Marrow Donor Program for another five years. The program helps match bone marrow donors and cord blood units with people in need.The bill overwhelmingly <a href="https://clerk.house.gov/Votes/2021109">passed</a> the House in a 415-2 vote on Thursday evening. Twelve lawmakers, including freshman Republican Rep. Madison Cawthorn of North Carolina, did not vote on the bill.A spokesman for Greene told Insider in a statement that the bill "opens the door" for the National Institutes of Health to "research the remains of babies who were murdered in the womb." "Nothing in this bill prevents the funding of aborted fetal tissue by taxpayers," he added.Boebert's office did not immediately respond to Insider's request for comment. The bill also directs the Department of Health and Human Services, the National Institutes of Health, and other related federal agencies to "conduct a review of the state of the science of using adult stem cells and birthing tissues to develop new types of therapies." It is a <a href="https://bloodstemcell.hrsa.gov/about/legislation">renewal</a> of the Stem Cell Therapeutic and Research Act of 2005, which Congress passed with bipartisan support and former President George W. Bush signed into law. It was reauthorized in 2010 and 2015 under the Obama administration. Fetal tissue research must be conducted <a href="https://grants.nih.gov/grants/policy/nihgps/html5/section_4/4.1.14_human_fetal_tissue_research.htm">according to federal and state law</a>.Democratic Rep. Doris Matsui of California, the lead sponsor of the bill, told Insider in a statement "it's unfortunate that some <keyword id="66537" type="ORGANIZATION" weightage="60" keywordseo="Republicans">Republicans</keyword> put partisan <keyword id="6358883" type="UNKNOWN" weightage="100" keywordseo="politics">politics</keyword> over helping blood <keyword id="6355291" type="UNKNOWN" weightage="60" keywordseo="Cancer">cancer</keyword> and blood disease patients in need.""Congress has consistently supported this life-saving cellular therapy program for over three decades," Matsui added.Matsui celebrated the bill's passage in the House on Thursday, and urged the Senate to follow suit. The Senate <a href="https://www.congress.gov/bill/117th-congress/senate-bill/288/cosponsors?r=73&amp;s=1&amp;searchResultViewType=expandedexpanded">version</a>, led by Democrat Jack Reed of Rhode Island, was introduced in February and has four co-sponsors, including two Democrats and two Republicans."Every three minutes, someone is diagnosed with a blood cancer. For patients and families facing these fatal diseases, a bone marrow or cord blood transplant may be the best treatment or only potential for a cure," Matsui said in a <a href="https://matsui.house.gov/news/documentsingle.aspx?DocumentID=2087">statement</a> on Thursday. "For the 1.3 million Americans suffering from blood cancer and bone marrow disorders, we must continue to make investments in these programs that have saved tens of thousands of lives."After the bill's passage, the National Marrow Donor Program <a href="https://twitter.com/BTMPublicPolicy/status/1382831305746911233">wrote on Twitter:</a> "Grateful to be one step closer to renewing our federal Program and the Nation's registry!"

GOP Reps. Lauren Boebert and Marjorie Taylor Greene were the only 'no' votes on a bill reauthorizing the National Marrow Donor Program

<ul class="summary-list"><li>Doctors suggested a <keyword id="6631668" type="UNKNOWN" weightage="60" keywordseo="bone-marrow">bone marrow</keyword> transplant to treat Kimberly Crompton's son, who has leukemia.</li><li>She learned that Black Americans find a perfect blood match about a third as often as white Americans. </li><li>Crompton set out to get more people of color on the <keyword id="148125" type="PERSON" weightage="60" keywordseo="bone-marrow-donation">bone marrow donation</keyword> registry. </li></ul>Kimberly Crompton's 14-year-old son, Jehvan, was supposed to be getting surgery on his foot. Ahead of the operation, doctors ran routine blood work, and they found something unexpected: Jehvan had the blood cancer Chronic Myeloid Leukemia (CML). The news was jarring, especially since Jehvan hadn't shown any obvious symptoms. "Really, a kid? My kid - has cancer?" Crompton told<a href="https://www.cnn.com/2021/02/28/us/kimberly-and-jehvan-crompton-be-the-match-iyw-trnd/index.html"> CNN</a>. <h2>Racial disparities in bone marrow donation</h2>Soon, Crompton learned that Jehvan needed to find a bone marrow donor, and that being Black could affect Jehvan's chances of finding a match. While white Americans have a 77% chance of finding a bone marrow match, Black Americans have just a 23% chance because fewer Black individuals are registered as donors, according to the Be The Match foundation."Currently, individuals of Black and African American ancestry are underrepresented on the registry, making it more difficult to find donor matches for those suffering from blood diseases like sickle cell," Mary Halet, director of Community Engagement at Be The Match, <a href="https://bethematch.org/news/news-releases/be-the-match-to-rally-black-and-african-american-marrow-donors/">said</a> in 2017. Crompton set out to try to change that by sharing Jahvan's story widely, and encouraging more people of color to become registered as donors. She wanted to add 200 people to the registry, but more than 11,000 have signed up due to her efforts. She told CNN she hopes that her son's story has highlighted the importance of African American donors. Bone marrow donation is important not only for people with blood cancer, like Jahvan. It's also the only known cure for sickle-cell disease, which<a href="https://www.cdc.gov/ncbddd/sicklecell/data.html"> disproportionately affects</a> people who are Black or Hispanic. <h2>Jehvan is still waiting for a match</h2>Despite the outpouring of support for donor registration, Jehvan still doesn't have a match. After a round of oral chemotherapy failed to slow the cancer's progression, he's now on a more invasive treatment plan while he awaits a bone marrow transplant. Until then, the family is relying on their faith to help them get through Jehvan's cancer treatment. Jehvan said he recognizes that signing up more potential donors could help him, but also thousands of other kids in need of a bone marrow transplant. "I see myself as another person trying to help everybody else out who won't ask for help," he told CNN. <a href="https://join.bethematch.org/s/landing?language=en_US&amp;ref=marrow17&amp;utm_campaign=priority_marrow&amp;utm_medium=cpc&amp;utm_source=google&amp;utm_content=donatebonemarrow&amp;gclid=Cj0KCQiAyoeCBhCTARIsAOfpKxjRzTcJ_XVO5nFbUjr76QsvyLXBE4ol1_MyiH5rYRRtFraKxfHCcn8aAggoEALw_wcBFraKxfHCcn8aAggoEALw_wcB">You can join the Bone Marrow Registry here</a>.

A mom is registering Black bone marrow donors to help save her 14 year-old son

<ul class="summary-list"><li>Drew Barrymore kept blood from both her daughters' umbilical cords.</li><li>Stem cells can be used to treat conditions including some cancers and immune system diseases.</li></ul>Drew Barrymore said she stored the blood from both of her daughters' umbilical cords in order to save their stem cells.The <a href="https://www.insider.com/drew-barrymore-charlies-angels-characters-didnt-act-like-men-2023-5">"Charlie's Angels"</a> actress banked her first daughter Olive's cord blood after doctors told her about the potential benefits, and did the same for her second daughter Frankie, she said on <a href="https://www.youtube.com/watch?v=Ld7cV1H_W9g" target="_blank" rel="noopener">"The Drew Barrymore Show" in a clip</a> shared on May 18. "It could have an impact on your family and even in some cases it could save your child's life," she said.This is because <a href="https://www.webmd.com/baby/should-you-bank-your-babys-cord-blood" target="_blank" rel="noopener">stem cells</a> can assume the form of other cells, and the fluid collected from the umbilical cord has 10 times more stem cells than that collected from<a href="https://www.insider.com/boy-needs-bone-marrow-transplant-mixed-race-finding-match-difficult-2022-3"> bone marrow — another source of stem cells. </a>They also rarely carry infectious diseases and are half as likely to be rejected as adult stem cells.Stem cells can be used to treat conditions such as certain immune system diseases, genetic and neurological disorders, and some forms of cancer.Dr. Christine Sterling, an OB/GYN and spokesperson for the company Cord Blood Registry that preserves and stores stem cells, which sponsored the segment on the show, told Barrymore: "The umbilical cord is made up of tissue and contains blood, both of are rich sources of stem cells with the potential to act like our body's own personal repair kit.""When you hear about something you can put in a bank to save you on another day, I immediately signed up both my daughters for it," Barrymore said.<h2>Private cord blood banking can be expensive and unnecessary </h2>However, the usefulness of routine cord blood banking for individual patients has been questioned. The American Academy of Pediatrics and the American Medical Association say the costs of storing umbilical cord blood as a form of "biological insurance" are high and outweigh the benefits, partly because the <a href="https://publications.aap.org/pediatrics/article/140/5/e20172695/37866/Cord-Blood-Banking-for-Potential-Future">blood may never be used. </a>And if it is used, it's more likely to go to a sibling, <a href="https://www.theatlantic.com/health/archive/2022/10/cord-blood-banking-transplant-cost-worth-it/671765/" target="_blank" rel="noopener">The Atlantic </a>reported. However some families may hope that more treatments will become available in the future. The likelihood that a child's privately banked cord blood will be used by them is extremely low, according to WebMD, for instance because the genetic mutations that caused the disorder needing treatment would be present in the blood. The AAP and AMA don't recommend routine cord blood banking, but it could be useful in cases where a sibling has a condition that could be treated using stem cells. The <a href="https://publications.aap.org/aapnews/news/14591">AAP said in 2017 </a>that most professional bodies favor public cord blood banking over private, for reasons including that they are free to use and serve the general public. In contrast, private banks only serve the individual family and can cost thousands of dollars without any return.<h2>Collecting the blood is painless for mother and baby</h2>According to WebMD, to carry collect the blood, doctors will cut the cord separating the mother and baby after birth and collect 40 milliliters — just under an ounce and a half — of blood.The blood is sealed in a bag and sent to storage, and the proceed ure is painless for the mother and baby.Barrymore shared the story of two brothers whose parents kept their umbilical cord blood. When their youngest was diagnosed with <a href="https://www.insider.com/doctors-use-hiv-in-gene-therapy-to-fix-bubble-boy-disease-2019-4">severe combined immunodeficiency</a>, a condition that meant he had a very weak immune system, stem cells from his brother's umbilical cord were used as a treatment, saving his life.

Drew Barrymore banked her daughters' umbilical cord blood for the stem cells — but experts say it's usually not worth it

<div class="KonaFilter image-container display-table"><div><div class="image"></div></div></div><ul class="summary-list"><li>Bone marrow transplants have now seemingly <a href="https://www.businessinsider.com/hiv-cure-stem-cell-transplant-future-of-aids-treatment-2019-3">cured a second man of HIV</a> after he was being treated for an aggressive form of cancer. </li><li>The treatment can be used for more than 70 different diseases, including many types of cancer, blood disorders, <a href="https://nordic.businessinsider.com/stem-cell-transplant-ms-treatment-2018-10/">autoimmune diseases</a> and more. </li><li>But bone marrow transplants also have serious risks and are quite expensive, making them a treatment of last resort. </li><li>Read on to learn about the many areas where the transplants can be used. </li></ul>The second person ever appears to have been successfully <a href="https://www.businessinsider.com/hiv-cure-stem-cell-transplant-future-of-aids-treatment-2019-3">cured of HIV</a>, a viral infection that attacks the body's immune system and can worsen into the devastating disease AIDS.The treatment wasn't a new scientific technique or high-tech drug. Instead, the cure was an accidental side-effect of a decades-old medical procedure that was once the basis for a <a href="https://www.nobelprize.org/prizes/medicine/1990/press-release/">Nobel Prize</a>: a bone marrow transplant.Bone marrow transplants have shown remarkable results in more than <a href="https://bethematch.org/patients-and-families/about-transplant/diseases-treated-by-transplant/other-diseases/">70 different diseases,</a> a wide-ranging list that includes cancers, inherited disorders and diseases of the immune system.But they are also very risky, intense and expensive, making them a treatment of last resort, and unlikely to become a viable treatment option for the roughly 37 million individuals living with HIV worldwide.See: <a href="https://www.businessinsider.com/hiv-cure-stem-cell-transplant-future-of-aids-treatment-2019-3">Scientists may have cured a man of HIV by injecting him with 'superpower' cells. Here's what it means for the future of AIDS treatment.</a>Bone marrow transplants essentially require first wiping out a patient's disease-fighting immune system, using either radiation or chemotherapy, to pave the way for the transplant.Patients then get an infusion of either bone marrow from a donor's hip or stem cells from blood, which eventually begins producing new, healthy cells so the body can fight infections again.Bone marrow is often compared to a factory that makes blood cells, so think of a bone marrow transplant like tearing the factory down and rebuilding it. Jay Feinberg was diagnosed with leukemia in the early 1990s and told he needed a bone marrow transplant to survive. Difficulty finding a donor match led him and his family to found the nonprofit <a href="https://www.giftoflife.org/">Gift of Life Marrow Registry,</a> where he now serves as CEO.Cancers like leukemias, lymphomas and multiple myeloma are some of the more common reasons that patients might get bone marrow transplants.<div class="KonaFilter image-container display-table"><div><div class="image"></div></div></div>But the procedure can also be used, sometimes in rare cases, to <a href="https://bloodcell.transplant.hrsa.gov/research/transplant_data/us_tx_data/survival_data/cvdrdiseaseglossaryfinal.pdf">treat </a>a dizzying array of other conditions, including breast cancer, blood disorders like beta thalassemia and sickle cell disease, autoimmune diseases like diabetes and <a href="https://nordic.businessinsider.com/stem-cell-transplant-ms-treatment-2018-10/">multiple sclerosis,</a> and neurological diseases like cerebral palsy.After years of searching, Feinberg eventually did find a match and has been leukemia-free for 24 years now. But finding matches for patients continues to be a problem, because there's a need for donors from <a href="https://www.businessinsider.com.au/be-the-match-registry-representation-2019-2">more diverse backgrounds</a>, he said.The transplant procedure carries risks of infection and other potential complications, including a life-threatening one in which cells from the donor attack the recipient. "It's not an easy process, but thankfully it works and it can cure your disease," he told Business Insider.<h2>The only known HIV cure, but not a solution</h2>Because bone marrow transplants are the only known HIV cure today, there's been some excitement about how they may be used.<a href="https://www.gwumc.edu/smhs/facultydirectory/profile.cfm?empName=Susan%20LeLacheur&amp;FacID=2046620615">Susan LeLacheur</a>, a physician assistant who treats individuals living with HIV in Washington, DC, says that a couple of her patients have asked about bone marrow transplants.She has explained to them that it's only a good option for those who also have cancer, in very specific circumstances, and that it's a difficult process. See: <a href="https://www.thisisinsider.com/trump-state-of-the-union-end-hiv-in-us-by-2030-2019-2">President Trump outlined a plan to 'eliminate' HIV in the US by 2030, and experts say it's actually possible</a>The two men who appear to have been cured of HIV only got bone marrow transplants because they had been diagnosed with aggressive cancers. Importantly, their bone marrow donors also had a genetic mutation that helps with resistance to a common type of HIV.People are excited because "the idea of a cure hasn't been out there for a while," she said. But "it's kind of more exciting for what it portends for the <a href="https://www.businessinsider.com/london-hiv-patient-second-worldwide-in-remission-hope-2019-3">future</a>," with biopharma companies using the technology as the basis for cutting-edge new approaches to treating disease.Effective <a href="https://www.thisisinsider.com/fda-approves-gileads-bictegravir-based-single-tablet-hiv-combination-2018-2">HIV treatments</a> also make it possible today for the estimated 1.1 million Americans who live with HIV to control it by taking pills each day. The medications allow many individuals to live long lives and avoid transmitting HIV, which is commonly <a href="https://www.cdc.gov/hiv/basics/transmission.html">spread</a> through such activities as sex and sharing needles or syringes. <a href="http://www.businessinsider.com/intelligence/ai-in-us-healthcare?IR=T&amp;utm_source=businessinsider&amp;utm_medium=ctgr&amp;utm_term=ctgr_leadgen&amp;utm_content=dhealth_ctgr_leadgen&amp;utm_campaign=dhealth_ctgr_leadgen_ai_in_us_healthcare"></a></hr>

The treatment that cured 2 men of HIV may also help with a remarkable array of more than 70 deadly diseases

By Sudipto Chowdhury Kolkata, May 9 () The COVID-19 pandemic has brought life to a screeching halt for many, but those with serious ailments such as blood disorders have been pushed to the edge with their lives now hanging by a thread in the absence of necessary medical interventions. Sonia Ghakkar, a Gurgaon resident, had been desperately looking for help, as her husband, a leukemia patient, waits for bone marrow transplant (BMT)."About two months ago, my husband was diagnosed with leukemia. Bone marrow transplant is his only chance of survival. We have sought permission from the health ministry for transport of blood stem cells, but to no avail. The match cannot reach the hospital under the present circumstances," she said.Stem cell transplant is the only cure for many patients suffering from blood disorders.According to a hematologist, it takes months, sometimes years, to find a donor, and many "high-risk" patients have limited time left.Transplants have come down to a meager 20 per cent nationwide, as most hospitals have postponed such processes, and prescribed additional chemotherapy sessions for the time being, in the wake of the coronavirus crisis, he said.Mumbai resident Danish Merchant had his BMT scheduled in March-end, but doctors had been postponing the process, citing logistical challenges as the reason."I am dependent on chemotherapy sessions for now. It is not just shooting up my bills, but also leaving me weak and scared. I pray that the situation comes under control at the earliest and my BMT procedure takes place before it gets too late," the 32-year-old said.Renowned hematologist and Padma Shri awardee Mammen Chandy said medical establishments have been conducting elective transplants."We have not stopped functioning; elective transplants are being conducted. Because of this lockdown, the blood platelet donation has also gone down. Nevertheless, all procedures are being done following the guidelines laid down to contain COVID-19," Chandy, Director, Tata Medical Centre, told from Vellore.Lalit Kumar, the head of the oncology department at Delhi's All India Institute of Medical Sciences (AIIMS), said the process could be delayed to an extent for the ones suffering from Thalassemia, but "high-risk" patients need doctor's intervention."Lockdown has affected transplantations, for sure. It has gone down to 20-30 per cent. There are patients located in Bihar, Uttar Pradesh, Rajasthan who cannot travel (to Delhi) as of now. The process can be delayed for patients suffering from thalassemia, but doctors have to take a call on high-risk patients suffering from Acute Myeloid Leukemia, Chronic Myeloid Leukemia, among other severe blood disorders."We have advised our patients after evaluating their health conditions to go for an extra session of chemotherapy to delay the process till an alternative can be worked out," he said.According to Kumar, voluntary donation has also dipped since the imposition of the lockdown on March 25.Expressing concern, Santanu Sen, a consultant in pediatrics, pediatric oncology and stem cell transplantation at Kokilaben Dhirubhai Ambani Hospital in Mumbai, said six critical patients were sent home, keeping in mind their safety amid the pandemic."All six of them were about to start their conditioning therapy. We have safely rescheduled the procedure keeping in mind the safety of the patients. Secondly, we also require a lot of blood support products. As of now we have sent them home. We are working very closely with the government to find an alternative, which will be beneficial for the patients," he said.Asked if setting up 'green corridors' would help in the movement of donors from one state to another, Sen said, "We have a patient whose brother is a match, but he is stuck in Rajasthan and cannot travel due to the shutdown."A special pass for these donors or a green corridor will definitely help. However, shortage of blood and necessary drugs at this juncture could also pose a problem," he explained.According to Sumati Misra, the head of counselling and transplant centre at DATRI -- the country's largest unrelated blood stem cell donors' registry -- the last donation was made by a man from Kochi to a recipient in Chennai in March-end.Germany-based DKMS BMST Foundation India, a non-profit bone marrow donor centre working from Bengaluru, said many donors are scared of contracting coronavirus.Talking to , the organisation's CEO in India, Patrick Paul said, "We conduct donation and cell collections in cooperation with hospitals. We also have international donors listed. Special care is taken to bring the donated stem cells in cargo planes. Donation, however, has been affected big time as people are scared of virus transmission," he said.A top official at the Union health ministry responsible for policy-making said states have been told to facilitate emergency medical services, but creating corridors at this point in time was "practically impossible"."As per our policy, the family member of a patient should approach the hospital or the institution concerned, which could then write to the state government for issuance of passes for hassle-free movement of donors and recipients," he said.The health ministry official also said that the national helpline number '104' was also meant to provide assistance in cases of emergencies other than COVID-19."They can dial 104 for information and also reach out to '1075' separately for such specific issues," he added. SCH RMS SRY

COVID-19 casts shadow on stem cell treatment across country

<div class="KonaFilter image-container display-table"><div><div class="image"></div></div></div><ul class="summary-list"><li>In the next generation of cancer treatments, patients could receive cells from strangers that have been engineered to better fight the disease. </li><li>An analysis done by <a href="https://pharmaintelligence.informa.com/">Informa Pharma Intelligence</a> for Business Insider shows that about $8.5 billion has been poured into licensing deals for this technology in recent years.</li><li>Nearly 30 drugs are being developed using this approach, according to the analysis.</li><li>Companies hope this "allogeneic CAR T" therapeutic approach could overcome limitations of existing cancer treatments, reaching more types of cancer in an easier, more convenient way.</li><li><a href="https://www.businessinsider.com/?hprecirc-bullet">Visit Business Insider's homepage for more stories.</a></li></ul>Wendy Fullem, a 54-year-old administrator at a New Jersey college, hadn't been feeling well for some time when, in fall 2016, she was diagnosed with leukemia. Leukemia is a type of blood cancer that comes in many forms. There were about <a href="https://www.lls.org/http%3A/llsorg.prod.acquia-sites.com/facts-and-statistics/facts-and-statistics-overview/facts-and-statistics">60,000 new cases</a> in the US last year, and one treatment option is a bone marrow transplant, a decades-old scientific procedure that has potential to <a href="https://www.businessinsider.com/what-is-a-bone-marrow-transplant-and-how-does-it-work-hiv-cure-2019-3">treat upwards of 70 different diseases,</a> including many types of cancer.Doctors quickly shuttled Fullem into an intense, weeks-long process of chemotherapy, followed by the transplant.Doctors had warned Fullem that the post-transplant process would be "like hell," and they were right, she said. She had "almost every side effect in the book," including one potentially deadly one that can accompany these transplants. But Fullem eventually made a full recovery. "It blows my mind," Fullem told Business Insider. "I am grateful for my life. When people say it's nice to see you, I say, 'It's nice to be seen.'" Today, companies are working to improve on the process Fullem went through, in hopes of supercharging this <keyword id="41551" type="ENTERTAINMENT" weightage="100" keywordseo="science">science</keyword> and making what is currently a highly individualized treatment more widely available. The new approach is called allogeneic CAR-T and is a variant of a cutting-edge treatment that some patients with cancer are today receiving. Called <a href="https://www.businessinsider.com/how-many-patients-car-t-cell-therapy-can-treat-2017-10">CAR-T cell therapy</a>, the current approach consists of collecting a patient's blood, reengineering their disease-fighting T-cells to better kill cancer tumors, and then putting the cells back in the body.You can think of the new experimental approach, allogeneic CAR-T, as a next-generation version. Instead of using a patient's own cells, the experimental tech uses immune cells from a healthy donor to treat diseases like cancer. It's named "allogeneic" after the cells it employs, which don't come from the patient's body. Roughly 30 individual allogeneic CAR-Ts are being developed today by biopharma companies for many different types of cancer, according to an analysis done for Business Insider by <a href="https://pharmaintelligence.informa.com/">Informa Pharma Intelligence</a>. Just a quarter, though, are far enough along to be tested in humans, the analysis shows, with drugmakers like <a href="https://www.allogene.com/">Allogene Therapeutics</a> and <a href="https://www.cellectis.com/">Cellectis SA</a> working on the most programs. All of the about 30 allogeneic CAR-Ts are experimental, meaning the tech isn't currently approved for use or to be sold. <div class="KonaFilter image-container display-table"><div><div class="image"></div></div></div>And at least $8.5 billion has been poured into licensing deals for this tech since 2014, according to the Informa Pharma Intelligence analysis. "We're waiting to see if that approach goes prime time," Jay Feinberg, the founder and CEO of the <a href="https://www.giftoflife.org/">Gift of Life Marrow Registry</a> told Business Insider.<div class="KonaFilter image-container display-table"><div><div class="image"></div></div></div><h2>New tech would be more convenient for patients, but faces technical challenges</h2>Allogeneic CAR-T therapies "may well be the future," Jill O'Donnell-Tormey, CEO of the nonprofit <a href="https://www.cancerresearch.org/about-cri/staff/ceo/jill-o-donnell-tormey-phd">Cancer Research Institute</a>, told Business Insider.That's because they should be easier and faster to make and deliver to patients, at least in theory.Today's CAR-T cell therapies take about three weeks to collect from the patient, engineer, and then infuse back into the patient. CAR-T products already approved and sold today are autologous, meaning they use the patient's own cells. In the US they include Gilead Sciences' <a href="https://www.businessinsider.com/car-t-cell-therapy-approval-gilead-kite-2017-10">Yescarta</a> and Novartis' <a href="https://www.businessinsider.com/fda-approves-novartis-kymriah-large-b-cell-lymphoma-cancer-treatment-2018-5">Kymriah</a>.The donor cells employed by allogeneic CAR-T, by contrast, can be held on standby, ready for patients in a matter of mere days. But to get there, drugmakers must first confront major technical challenges. Allogeneic CAR-T hinges on using the immune system against cancer cells, but it also runs the risk of triggering the immune system in potentially deadly ways. "Your body naturally, because you have an immune system, is going to try to reject anything you put into it," said Mizuho analyst Salim Syed. "This is why we don't have [allogeneic CAR-T therapies] right now."Companies like <a href="https://www.atarabio.com/">Atara Biotherapeutics</a> are trying to get around that by better matching immune cells with a patient's cells, to avoid an attack. Another approach, employed by companies like Allogene, involves reengineering cells and also knocking out receptors on the surface of a T-cell that play a key role in these rejections, Syed said.Others are turning to a different type of "natural killer" immune cell, in hopes of avoiding this issue entirely. Crucially, the experimental tech still has to be proven out. But big pharma companies are all starting to talk about it, especially if they sell or are developing other similar cell therapies, Syed said.That list includes Gilead, <a href="https://www.celyad.com/en/news/celyad-grants-to-novartis-a-non-exclusive-license-for-its-allogeneic-tcr-deficient-car-t-cells-patents">Novartis</a>, and Celgene, which is in the process of <a href="https://news.bms.com/press-release/corporatefinancial-news/bristol-myers-squibb-shareholders-approve-celgene-acquisition">being bought by Bristol-Myers Squibb</a>. "Is it a threat to the autologous version? It can be. We don't know yet," Mizuho's Syed said. "Anyone who has an autologous CAR-T needs to think about allo."<ul class="read-more-links"><li>Read more:</li><li><a href="https://www.businessinsider.com/sempre-health-pitch-deck-strategy-drug-coupons-medication-adherence-2019-5">We got a look at the pitch deck of buzzy Silicon Valley health-tech startup Sempre Health. It reveals how a $4 billion industry is ripe for disruption.</a></li><li><a href="https://www.businessinsider.com/targeted-protein-degradation-therapy-treat-cancer-1-billion-investment-arvinas-2019-5">Scientists are working on cancer treatments that attack the disease's 'Holy Grail.' Big pharma and biotechs have already invested more than $1 billion.</a></li><li><a href="https://www.businessinsider.com/merck-hiv-drug-implant-prevention-and-treatment-2019-4">We got an inside look at pharma giant Merck's strategy to upend the $20 billion HIV drug market using tech borrowed from birth control</a></li><li><a href="https://www.businessinsider.com/how-to-invest-in-biotech-stocks-fidelitys-eirene-kontopoulos-2019-4">The woman who runs a $2.5 billion Fidelity fund told us about the 10-item 'mental checklist' she uses to choose the most promising stocks in a notoriously risky field</a></li></ul><a href="http://www.businessinsider.com/intelligence/ai-in-us-healthcare?IR=T&amp;utm_source=businessinsider&amp;utm_medium=ctgr&amp;utm_term=ctgr_leadgen&amp;utm_content=dhealth_ctgr_leadgen&amp;utm_campaign=dhealth_ctgr_leadgen_ai_in_us_healthcare"></a></hr>

'That may well be the future': Companies have poured $8.5 billion into creating a new version of a cutting-edge, highly personalized cancer treatment

"Cancer."
That's the only word April Conyers, 33, remembers hearing in the hospital on Oct. 10.
She was sitting with her fiance of two months, Drew Olanoff.&#xa0;She knows the doctor said a lot of other things, about oncologists and chemotherapy and staying positive, but it's all a blur.
Olanoff, 34, had gone to the hospital at Conyers'&#xa0;urging. He was running a 102-degree fever and had stomach pains. They thought he might have appendicitis. Instead, he had diverticulitis, a pesky but curable infection.
But the CAT scan also revealed tumors lining Olanoff's gut. After five years in remission, his Hodgkin's Lymphoma had returned.&#xa0;
Olanoff was shocked. He had a physical the week prior, and had been told he was in perfect health.&#xa0;
The first time Olanoff had cancer, the signs were more obvious. At age 29, he discovered a lump the size of a softball on his neck - stage 3 lymphoma. This time,&#xa0;he mostly felt fine.
He had been feeling tired, but he assumed that was from flying to Berlin from San Francisco frequently for his job. He had some back pain, like most people experience on occasion. That turned out to be a tumor pressing on a nerve.&#xa0;

"I think after you have a diagnosis like cancer it follows you around for the rest of your life," he says. "I've always carried [the fear it would return] with me. I go in for something like taking out my appendix out then they tell me they found tumors. It's like, 'No, that's to what I wanted to hear thank you, can you take that back?'"
For Olanoff and his soon-to-be bride, it's been a wild few months of accomplishments in both work and life - but that's all been interrupted by cancer.
The couple met over email a few years ago, when Olanoff was a writer for technology site The Next Web, and Conyers&#xa0;pitched him her startup clients at Brew PR. They officially met during TechCrunch Disrupt in New York at the Ace Hotel. Olanoff says he fell in love right there. "I told her, 'Sorry, I can't write about your companies anymore [due to conflict of love interest],'" he says.
Conyers&#xa0;moved to San Francisco for Olanoff. She began a new job in September as head of communications at a delivery startup, Postmates. Olanoff also began a new job in June, as Global Communications Director for an Instagram-like startup, EyeEm. He had been working at Yahoo when a mentor left to join EyeEm and asked Olanoff to come with him.&#xa0;
Conyers&#xa0;and Olanoff got engaged on Aug. 27, a Wednesday - the same day Conyers&#xa0;resigned from her job at Brew PR to join Postmates. She remembers preparing a taco dinner when their dog, Apollo, trotted over. A small box was nestled in his tiny shirt pocket along with a scribbled note. When Conyers looked up, Olanoff was on one knee.
After just two weeks at Postmates, Conyers&#xa0;and Olanoff received the news at the hospital, and their worlds turned upside down. Both of their employers offered to help Olanoff however they could.
Since then, Olanoff estimates he's had 25 doctor appointments. Every day he has chemotherapy, Conyers writes him a note in a card and organizes dinner dates at the hospital. His last round ended on Christmas Eve. On one particularly rough day, Olanoff told Conyers&#xa0;he wouldn't blame her if she left him. She told him to shut the hell up.
For a cancer patient - or anyone for that matter - Olanoff is upbeat. He radiates positivity, a natural glow which has won him high-up friends in the tech and celebrity circuits. Yahoo CEO Marissa Mayer, for example, personally asked him to join her company. She had worked with him during her Google days when he was a TechCrunch reporter. Twitter co-founder Evan Williams gave Olanoff the handles @drew and @yoda. Celebrity Drew Carey helped Olanoff raise more than $1 million for cancer research the last time he was diagnosed, thanks to a Twitter interaction Olanoff instigated.&#xa0;
(In 2009, Olanoff created a Twitter movement for charity,&#xa0;<a href="http://www.blamedrewscancer.com">#blamedrewscancer</a>, which encouraged people to complain about life's small annoyances; Ryan Seacrest, Drew Carey, Alyssa Milano and Lance Armstrong all participated. He also auctioned off his Twitter handle, @drew, to Drew Carey, which Carey ultimately let him keep.)
Being so public about his cancer last time was exhausting for Olanoff. He didn't want to go through that again. But when the doctors told Olanoff he needed a stem cell transplant, Olanoff changed his mind.&#xa0;

This time, instead of using Twitter to raise money, Olanoff wants to <a href="https://medium.com/@drew/thats-really-not-what-i-ordered-again-cd51b313f11a">raise awareness for the bone marrow registry</a>. If he can use his influence in Silicon Valley to persuade even a few people to sign up, he can save lives - maybe even his own.
"April and I talked about [me going public with cancer again]," Olanoff says. "I felt guilty not talking about it. I felt selfish...This time there's a clear action and I can educate people."
The concept of giving blood is well known. Donating bone marrow seems scarier. Olanoff hopes re-launching his website, <a href="http://www.blamedrewscancer.com">BlameDrewsCancer.com</a>, and writing about his situation will make bone marrow donations less taboo.
"People understand giving blood. They prick your arm, give you a cookie and you leave. You never know if your blood gets used or not. [Bone marrow] is a situation where, if you get that call, you can talk to the person who needs it. If you want you can get to know them. You don't have to say yes. You don't have to do the donation." 
Olanoff's efforts to educate the world about bone marrow and stem cell transplants have already helped. The last time he had cancer, he held a "blameathon" to raise money for charity with live bands and mouth swabs. Four years later, he got a call from an attendee who told Olanoff, "I'm a match for somebody." 

When Olanoff was re-diagnosed, Conyers&#xa0;promptly signed herself up for the registry. She was sent cotton swabs in the mail and rubbed all four corners of her mouth in under five minutes. One week later, her DNA was added to the online database.
If there is one good thing about having cancer, it's that it puts life in rather harsh perspective.
"Things that annoyed you don't annoy you anymore," Olanoff says. "Things you get stressed out about aren't stressful anymore. You refocus on family and friends. 
"The perspective on life," he adds, "is a reward."
Conyers&#xa0;and Olanoff are still planning their wedding. They hope to get married in late 2015 or 2016, once Olanoff has beaten his cancer. 
Again.
If you are interested in becoming a bone marrow donor or joining the registry to see if you could be someone's match, visit <a href="http://bethematch.org/support-the-cause/donate-bone-marrow/join-the-marrow-registry/">BeTheMatch.com</a>.
Here's more on the process, but definitely read more on the website and/or ask your physician before you decide to sign up:
<ul>
<li>You should be between the ages of 18 and 44, although people between ages 45 and 60 can still apply to get registered online. If you register, your DNA information will remain in the bone marrow registry until you turn 61 or call to opt out.</li>
<li>Getting swabbed takes about five minutes and you can get a kit sent to you in the mail.</li>
<li>According to Be The Match, only one in forty people who join the registry get asked for additional testing (a blood test). One in 300 gets matched with a patient. One in 500 actually donates bone marrow.&#xa0;</li>
<li>If you are matched with a patient, the process takes about&#xa0;20 to 30 hours over a 4- to 6-week period, during which you'll have doctors appointments then go under anesthesia and donate your bone marrow. You may also need injections before your stem cells are donated.&#xa0;</li>
</ul>

Former Yahoo Drew Olanoff, 34, Should Be Planning His Wedding - But Now He Has To Fight Cancer...Again

<a href="https://www.gettyimages.com/detail/news-photo/kaylen-smith-demonstrates-how-to-don-the-protective-gear-news-photo/1203978099?adppopup=true">Erin Clark/The Boston Globe via Getty Images</a><ul class="summary-list"><li>Nurses detailed a lack of coordination between governments and hospitals over protocols that could help stem the outbreak, with mask shortages a notable example</li><li>Nurses were already working at full capacity before the outbreak, and many are facing a choice between paying their bills and calling in sick if they get exhausted or even catch the coronavirus.</li><li>In the case of a "domino effect" where nurses begin to get sick, one nurse warned, a nurse staffing crisis will only make the current health crisis worse.</li><li>If you're a nurse with observations to share during the novel coronavirus outbreak, email aakhtar@businessinsider.com.</li><li><a href="https://www.businessinsider.com/?hprecirc-bullet">Visit Business Insider's homepage for more stories</a>.</li></ul>Maeleigh Soper, a registered travel nurse in Seattle, has been rationing masks and hand sanitizers for the past week.She said her hospital, which went through a month's worth of masks and hand sanitizers in three days, suspects that patients and families have been stealing medical supplies amid the novel coronavirus outbreak.The novel coronavirus, which spread from China in late December, has since infected <a href="https://www.businessinsider.com/china-virus-everything-we-know-deadly-2019-ncov-wuhan-spread-2020-1">at least 169,000 people in every continent besides Antarctica</a>.US <a href="https://www.businessinsider.com/coronavirus-us-lockdown-close-schools-bars-travel-2020-3">localities</a> and <a href="https://www.businessinsider.com/major-events-cancelled-or-postponed-due-to-the-coronavirus-2020">businesses</a> have taken steps to lessen the disease's spread, so that the healthcare system won't be overwhelmed by new patients. But Business Insider talked to nine nurses in hospitals nationwide, who said equipment shortages are putting their health and that of their patients at risk, as the novel coronavirus continues to spread.Hospitals cannot limit the number of patients a nurse can legally care for at once in every state except for California, and nurses that care for more than six patients in a day get burned out and cannot provide adequate patient care, <a href="https://www.businessinsider.com/nurses-to-go-on-strike-for-better-patient-ratios-2019-9">according to research from Linda Aikens</a>. Nurses reported grappling with equipment shortages, understaffing, and a lack of coordination on protocols between health systems and the government. "I think the real message we need to tell people is that this is the calm before the storm," Marcia Santini, a registered nurse at an emergency room in California, told Business Insider. "We need to keep our healthcare workers healthy, and if they get sick, that would collapse the healthcare system."<h2>Nurses are facing mask shortages - and they have called on the government and hospital systems for more resources</h2>Santini said her hospital was crowded and nearly filled to occupancy - before the coronavirus outbreak. Like Soper, Santini said her hospital has had a shortage of proper medical supplies like gowns and masks. On March 10, <a href="https://www.nationalnursesunited.org/press/cdc-further-weakens-covid-19-guidance-nurses-outraged-failed-federal-state-local-employer">the National Nurses United union called on the White House and hospital systems</a> to ensure that nurses have enough protective equipment. A union survey found only 30% of nurses report having enough equipment to deal with the virus outbreak.Soper works in her hospital's oncology department, where patients receiving bone marrow transplants have severely comprised immune systems. Soper said her biggest fear is passing on the virus, potentially deadly to patients with comorbidities, to her patients. "We need to be protected because once you start the domino effect," Santini said, referring to one healthcare worker getting sick and spreading the disease to other staffers, "then you're going to have a staffing crisis."AP Photo/Ted S. Warren<h2>Nurses described feeling frustrated at the lack of coordination from hospitals and the government over proper protocol</h2>Monica, a registered nurse who works in a rural hospital in Washington state, identified four patients last week who she thought should have been tested for COVID-19. (Business Insider confirmed Monica's identity before publishing this article).But due to confusion from the state's Department of Health and hospital providers, none received a test. The <a href="https://www.businessinsider.com/coronavirus-deaths-washington-nursing-home-outbreak-2020-3">first man to die from coronavirus in the US</a> lived in a long-term care facility in Washington state. Healthcare workers and other residents in the nursing home were <a href="https://www.businessinsider.com/coronavirus-deaths-washington-nursing-home-outbreak-2020-3">also exposed to the virus</a>.Monica's hospital, which has already faced staffing shortages, asked her to work extra shifts on top of her six continuous night shifts. Coupled with a lack of proper protective gear, Monica told Business Insider she was frustrated by the lack of coordination between federal and state governments and hospital systems on figuring out coronavirus protocols. Marie Spaner, a hospital nurse in the Los Angeles area, told Business Insider that she also felt frustrated at her hospital's lack of planning. Her hospital has not changed cleaning or sanitation protocols since the outbreak, nor has it limited visitors."It's frustrating and frightening. If we can't have things implemented properly in the hospital then it's a danger for us [nurses] and to the patients," Spaner told Business Insider. "We're just grossly unprepared."Reuters<h2>For nurses themselves, getting sick means losing pay</h2>Many nurses told Business Insider that if they take time off work, they won't get paid.Carmen Martinez, who works as a nurse in the registry department in a California hospital, said her hospital recently stopped screening patients with fevers below 104 - even if they present other coronavirus symptoms.Without screening patients for coronavirus when their temperature is below 104 - coupled with the shortages of protective equipment - Martinez said she was worried most about getting sick and needing to take time off work. Two weeks without work means Martinez won't be able to pay her bills."I don't think America knows how much how much is at stake for us," Martinez told Business Insider. "We're putting our lives at risk right now. I think everybody needs to remember that we're in the front lines were at risk, but there has to be provision made for us." <h3>NOW WATCH: <a href="https://www.businessinsider.com/youtube-influencer-creator-crash-course-how-to-make-money-ads-2020-2">CRASH COURSE: An influencer explains how YouTube ads work, her advice for making more money, and how much she earns</a></h3>

The government is failing our most important front-line defense against COVID-19: Nurses

<div class="image-container float_right" style="width:400px"><div class="image"></div>Getty</div>
<ul>
<li>The saga continues! <keyword id="3318" type="PERSON" weightage="60" keywordseo="Rihanna">Rihanna</keyword><a href="http://www.tmz.com/2013/02/06/chris-brown-court-hearing-probation-rihanna/?adid=hero1" target="_blank"> accompanied Chris Brown</a><a href="http://www.tmz.com/2013/02/06/chris-brown-court-hearing-probation-rihanna/?adid=hero1" target="_blank"> to court Wednesday for a probation hearing</a> stemming from assaulting Rihanna in 2009. During the hearing, the judge requested more information before thoroughly examining whether Brown faked his community service, as was alleged on Tuesday. After Rihanna blew him a kiss during proceedings, the two left the court arm-in-arm. <a href="http://www.tmz.com/2013/02/06/chris-brown-court-hearing-probation-rihanna/" target="_blank">See photos of the two smiling here &gt;</a></li>
<li>Following a bone marrow transplant, Robin Roberts <a href="http://www.tmz.com/2013/02/06/chris-brown-court-hearing-probation-rihanna/" target="_blank">will be returning to "Good Morning America" on February 20.</a></li>
<li>Meanwhile, <keyword id="6357837" type="PERSON" weightage="60" keywordseo="Kim-Kardashian">Kim Kardashian</keyword> <a href="http://www.gossipcop.com/khloe-kardashian-cousin-cici-bone-marrow-donor-stem-cell-transplant-donation-cancer-armenian-descent/" target="_blank">wrote a blog post "desperately" pleading for a bone marrow transplant for her cousin</a>. “My cousin, Cici, has been battling cancer for 17 years and she is no longer responding to the chemotherapy drugs. Her best option now is a bone marrow stem cell transplant, which would hopefully give her many more years to live ... Because Cici is Armenian, the donor must be of Armenian descent, so we are asking every Armenian to reach out to the bone marrow registry and sign up with hopes of finding a match for Cici.”</li>
<li>Justin Timberlake has <a href="http://www.vulture.com/2013/02/justin-timberlake-20-20-experience-track-list.html" target="_blank">released his new album art and track list for his upcoming "The 20/20 Experience."</a> Song titles include "Strawberry Bubblegum" and "Spaceship Coupe."</li>
<li>Naomi Campbell had less-than-model behavior as she <a href="http://www.nypost.com/p/pagesix/face_it_naomi_PFCVrDHBfwAheS6nRsIRxN" target="_blank">arrived two hours late for the NYC premiere of her new reality show</a> "The Face" on Oxygen co-starring top models Karolina Kurkova and Coco Rocha.</li>
<li>In a CW fan's dream come true, Gossip Girl's real-life Blair Waldorf, Leighton Meester, is <a href="http://www.gossipcop.com/leighton-meester-adam-brody-dating-couple-relationship/" target="_blank">dating the O.C.'s Seth Cohen</a> played by Adam Brody. </li>
<li>The Office star Ellie Kemper <a href="http://www.hollywoodreporter.com/live-feed/offices-ellie-kemper-star-nbcs-419103" target="_blank">gets her own NBC spin-off show</a> — a past and present comedy about a chubby, awkward yet incredibly confident 13-year-old who grew up to be a 31-year-old woman who still marches to the beat of her own drum.</li>
<li>If Lena Dunham had to kill off a GIRLS cast member, she says it would be Zosia Mamet's character, Shoshanna.</li>
</ul>
SEE ALSO:<a href="http://www.businessinsider.com/cbs-issues-no-nudity-wardrobe-advisory-for-grammy-awards-2013-2"> CBS issues no-nudity 'wardrobe advisory' for Sunday's Grammy Awards &gt;</a>

You Searched For "bone marrow registry" and got 11 results

A 7-year-old boy needs a bone-marrow transplant. Being mixed-race makes it almost impossible to find one.

Elizabeth Broadbent

GOP Reps. Lauren Boebert and Marjorie Taylor Greene were the only 'no' votes on a bill reauthorizing the National Marrow Donor Program

Oma Seddiq

A mom is registering Black bone marrow donors to help save her 14 year-old son

Kelly Burch

Drew Barrymore banked her daughters' umbilical cord blood for the stem cells — but experts say it's usually not worth it

Amber Middleton

The treatment that cured 2 men of HIV may also help with a remarkable array of more than 70 deadly diseases

Emma Court

COVID-19 casts shadow on stem cell treatment across country

PTI

'That may well be the future': Companies have poured $8.5 billion into creating a new version of a cutting-edge, highly personalized cancer treatment

Emma Court

Former Yahoo Drew Olanoff, 34, Should Be Planning His Wedding - But Now He Has To Fight Cancer...Again

Alyson Shontell

The government is failing our most important front-line defense against COVID-19: Nurses

Allana Akhtar

Rihanna Accompanied Chris Brown To Court, Blew Him A Kiss During Proceedings - Here's Today's Buzz

Aly Weisman

These six people donated their kidneys to complete strangers and saved 140 lives in the process - here's why

Caroline Praderio

Popular Keywords

Buying Guides